These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20727768)

  • 1. Commentary: the past, present and future of imaging in multiple sclerosis.
    Kam A
    J Clin Neurosci; 2010 Nov; 17(11):1482. PubMed ID: 20727768
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of modern magnetic resonance techniques to monitor disease evolution in multiple sclerosis.
    Filippi M; Rocca MA
    Adv Neurol; 2006; 98():167-83. PubMed ID: 16400834
    [No Abstract]   [Full Text] [Related]  

  • 3. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.
    Geurts JJ; Roosendaal SD; Calabrese M; Ciccarelli O; Agosta F; Chard DT; Gass A; Huerga E; Moraal B; Pareto D; Rocca MA; Wattjes MP; Yousry TA; Uitdehaag BM; Barkhof F;
    Neurology; 2011 Feb; 76(5):418-24. PubMed ID: 21209373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging in multiple sclerosis.
    Napoli SQ; Bakshi R
    Rev Neurol Dis; 2005; 2(3):109-16. PubMed ID: 16400309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What do we really see when we look at magnetic resonance images?
    Filippi M; Hartung HP
    Ann Neurol; 2007 Sep; 62(3):207-9. PubMed ID: 17894367
    [No Abstract]   [Full Text] [Related]  

  • 6. The increasing influence of medical image processing in clinical neuroimaging.
    Barillot C
    Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52(6):16-23. PubMed ID: 17543205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study.
    Moraal B; Pohl C; Uitdehaag BM; Polman CH; Edan G; Freedman MS; Hartung HP; Kappos L; Miller DH; Montalban X; Lanius V; Sandbrink R; Barkhof F
    Arch Neurol; 2009 Nov; 66(11):1345-52. PubMed ID: 19901165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative analysis techniques for brain MRI: applications in multiple sclerosis].
    Grimaud J; Zhu YM; Rombaut M
    Rev Neurol (Paris); 2002 Mar; 158(3):381-9. PubMed ID: 11976603
    [No Abstract]   [Full Text] [Related]  

  • 10. Starting early: MRI evidence of gray matter atrophy in children with multiple sclerosis.
    Banwell BL; Sled JG
    Neurology; 2008 Mar; 70(13 Pt 2):1065-6. PubMed ID: 18362266
    [No Abstract]   [Full Text] [Related]  

  • 11. [Semi-automated quantification of MRI high signals observed in multiple sclerosis].
    Cabanis EA; Lyon-Caen O; Iba-Zizen MT; Stievenart JL; Takahashi J; Lopez A; Stoffels C; Majdalani A; Thibierge M; Carteret M
    Ophtalmologie; 1990; 4(1):116-22. PubMed ID: 2250930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can MRI reveal phenotypes of multiple sclerosis?
    Guttmann CR; Meier DS; Holland CM
    Magn Reson Imaging; 2006 May; 24(4):475-81. PubMed ID: 16677954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Approaches to segment multiple-sclerosis lesions on conventional brain MRI].
    Souplet JC; Lebrun C; Chanalet S; Ayache N; Malandain G
    Rev Neurol (Paris); 2009 Jan; 165(1):7-14. PubMed ID: 18808780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of MRS and fMRI in multiple sclerosis.
    Tartaglia MC; Arnold DL
    Adv Neurol; 2006; 98():185-202. PubMed ID: 16400835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of MRI as an outcome measure in clinical trials.
    Li DK; Li MJ; Traboulsee A; Zhao G; Riddehough A; Paty D
    Adv Neurol; 2006; 98():203-26. PubMed ID: 16400836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of multiple sclerosis lesion load and brain tissue volumetry using multiparameter MRI: methodology and reproducibility.
    Ding Z; Preiningerova J; Cannistraci CJ; Vollmer TL; Gore JC; Anderson AW
    Magn Reson Imaging; 2005 Apr; 23(3):445-52. PubMed ID: 15862645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis lesion quantification using fuzzy-connectedness principles.
    Udupa JK; Wei L; Samarasekera S; Miki Y; van Buchem MA; Grossman RI
    IEEE Trans Med Imaging; 1997 Oct; 16(5):598-609. PubMed ID: 9368115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR image analysis in multiple sclerosis.
    Nyul LG; Udupa JK
    Neuroimaging Clin N Am; 2000 Nov; 10(4):799-816 ,x. PubMed ID: 11359726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.
    Filippi M; Rocca MA; Calabrese M; Sormani MP; Rinaldi F; Perini P; Comi G; Gallo P
    Neurology; 2010 Nov; 75(22):1988-94. PubMed ID: 21115953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging in multiple sclerosis.
    Haller S; Pereira VM; Lalive PH; Chofflon M; Vargas MI; Lövblad KO
    Top Magn Reson Imaging; 2009 Dec; 20(6):313-23. PubMed ID: 21187724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.